High Resolution Removal of Virus from Protein Solutions Using a Membrane of Unique Structure

Author:

DiLeo Anthony J.,Allegrezza Anthony E.,Builder Stuart E.

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Reference27 articles.

1. Lubiniecki, A.S. 1988. Safety of recombinant biologics: Issues and emerging answers, p. 3: 3–12. In: Animal Cell Biotechnology, Spier, R.E. and Griffiths, J.B. (Eds.). Academic Press, London, UK.

2. Builder, S., van Reis, R., Paoni, N., Ogez, J. 1989. Process development and regulatory approval of tissue-type plasminogen activator, In: Advances in Animal Cell Biology and Technology for Bioprocesses. Spier, R.E., Griffiths, J.B., Stephenne, J., Crooy, P.J. (Eds.). Butterworths, Stoneham, MA. 452–464.

3. Division of Blood and Blood Products, U. S. Food and Drug Administration. 1984. Points to consider in the characterization of cell lines used to produce biologicals.

4. Office of Biologicals Research and Review, U. S. Food and Drug Administration. 1985. Points to consider in the production and testing of new drugs and biologicals by recombinant DNA technology.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3